Sue Leurgans to Middle Aged
This is a "connection" page, showing publications Sue Leurgans has written about Middle Aged.
Connection Strength
0.442
-
Effect of donepezil on motor and cognitive function in Huntington disease. Neurology. 2006 Oct 10; 67(7):1268-71.
Score: 0.034
-
Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7.
Score: 0.032
-
Elevated neuroinflammation, autoimmunity, and altered IgG glycosylation profile in the cerebral spinal fluid of severe COVID-19 patients. Brain Behav Immun. 2025 Aug; 128:289-302.
Score: 0.031
-
A multicenter retrieval study of the taper interfaces of modular hip prostheses. Clin Orthop Relat Res. 2002 Aug; (401):149-61.
Score: 0.026
-
A comparison of osteopathic spinal manipulation with standard care for patients with low back pain. N Engl J Med. 1999 Nov 04; 341(19):1426-31.
Score: 0.021
-
Association of cognitive activity and neurocognitive function in blacks and whites with HIV. AIDS. 2017 01 28; 31(3):437-441.
Score: 0.017
-
Loneliness in Older Black Adults with Human Immunodeficiency Virus Is Associated with Poorer Cognition. Gerontology. 2017; 63(3):253-262.
Score: 0.017
-
Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample. Mol Neurodegener. 2015 Dec 02; 10:65.
Score: 0.016
-
Change in motor function and adverse health outcomes in older African-Americans. Exp Gerontol. 2015 Oct; 70:71-7.
Score: 0.016
-
Physical activity, motor function, and white matter hyperintensity burden in healthy older adults. Neurology. 2015 Mar 31; 84(13):1294-300.
Score: 0.015
-
Renal effects of oral prostaglandin supplementation after ibuprofen in diabetic subjects: a double-blind, placebo-controlled, multicenter trial. J Am Soc Nephrol. 1995 Mar; 5(9):1684-8.
Score: 0.015
-
Residual decline in cognition after adjustment for common neuropathologic conditions. Neuropsychology. 2015 May; 29(3):335-43.
Score: 0.015
-
Industrial wrist motions and incidence of hand/wrist cumulative trauma disorders. Ergonomics. 1994 Sep; 37(9):1449-59.
Score: 0.015
-
A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov Disord. 2013 Aug; 28(9):1230-40.
Score: 0.013
-
Quantification of the fragmentation of rest-activity patterns in elderly individuals using a state transition analysis. Sleep. 2011 Nov 01; 34(11):1569-81.
Score: 0.012
-
CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol. 2011 Mar; 69(3):560-9.
Score: 0.012
-
Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment. Arch Neurol. 2011 Mar; 68(3):351-6.
Score: 0.012
-
Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord. 2009 Jul; 15(6):471-4.
Score: 0.010
-
Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia. J Mot Behav. 2008 Jul; 40(4):301-13.
Score: 0.010
-
Association of daytime napping and Parkinsonian signs in Alzheimer's disease. Sleep Med. 2006 Dec; 7(8):614-8.
Score: 0.009
-
Transcultural comparison of psychogenic movement disorders. Mov Disord. 2005 Oct; 20(10):1343-5.
Score: 0.008
-
White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging. 2006 May; 27(5):663-72.
Score: 0.008
-
Focal neurological deficits and West Nile virus infection. Clin Infect Dis. 2005 Apr 01; 40(7):e59-62.
Score: 0.008
-
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord. 2004 Dec; 10(8):507-10.
Score: 0.008
-
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Arch Neurol. 2004 Aug; 61(8):1280-4.
Score: 0.007
-
Clinical evidence for cervical myelopathy due to Chiari malformation and spinal stenosis in a non-randomized group of patients with the diagnosis of fibromyalgia. Eur Spine J. 2004 Oct; 13(6):516-23.
Score: 0.007
-
Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology. 2004 Jan-Apr; 23(1-2):61-6.
Score: 0.007
-
Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord. 2003 Oct; 10(1):9-14.
Score: 0.007
-
Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA. 2003 Jun 11; 289(22):2947-57.
Score: 0.007
-
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord. 2002 Mar; 17(2):283-8.
Score: 0.006
-
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Arch Neurol. 2001 Feb; 58(2):209-13.
Score: 0.006
-
Acute orthostatic hypotension when starting dopamine agonists in Parkinson's disease. Arch Neurol. 2000 Oct; 57(10):1461-3.
Score: 0.006
-
"On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12.
Score: 0.005
-
Regulators of proliferation and apoptosis in carcinoma of the larynx. Laryngoscope. 1998 May; 108(5):630-8.
Score: 0.005